Deakstadieđáhus: THE POLITICS OF REGULATION WITHIN THE 'MODERNIZED' NHS: THE CASE OF BETA INTERFERON AND THE 'COST-EFFECTIVE' TREATMENT OF MULTIPLE SCLEROSIS